Australia markets closed

Imagion Biosystems Limited (IBX.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.07400.0000 (0.00%)
At close: 02:50PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 2.42M
Enterprise value 9.33M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.37
Price/book (mrq)3.84
Enterprise value/revenue 5.67
Enterprise value/EBITDA -0.81

Trading information

Stock price history

Beta (5Y monthly) 1.89
52-week change 3-88.44%
S&P500 52-week change 321.23%
52-week high 31.4400
52-week low 30.0730
50-day moving average 30.0804
200-day moving average 30.3657

Share statistics

Avg vol (3-month) 373.63k
Avg vol (10-day) 3N/A
Shares outstanding 532.65M
Implied shares outstanding 632.65M
Float 829.99M
% held by insiders 18.14%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:40
Last split date 316 Nov 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -252.26%
Operating margin (ttm)-96.05%

Management effectiveness

Return on assets (ttm)-99.05%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)5.18M
Revenue per share (ttm)0.17
Quarterly revenue growth (yoy)60.00%
Gross profit (ttm)N/A
EBITDA -10.36M
Net income avi to common (ttm)-13.07M
Diluted EPS (ttm)-0.4300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)227.08k
Total cash per share (mrq)0.01
Total debt (mrq)7.14M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.11
Book value per share (mrq)-0.14

Cash flow statement

Operating cash flow (ttm)-8.32M
Levered free cash flow (ttm)-4.38M